PKU mystery: why do some patients thrive despite high phe levels?
NCT ID NCT07406009
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how blood phenylalanine (Phe) levels affect thinking, emotions, and daily functioning in adults with PKU. Researchers will ask 30 adults with PKU and their relatives to complete questionnaires. The goal is to understand why some people with high Phe levels have no major problems, while others do, so that future care can be more personalized.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHENYLKETONURIA (PKU) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Hidden weight problem: PKU adults face higher obesity risk, scientists investigate why
- New oral drug aims to tame PKU's toxic protein buildup
- Experimental enzyme injection aims to tame PKU's toxic amino acid
- Tiny tablets could make PKU management easier for patients
- New PKU drug JNT-517 moves to Long-Term safety trial
- New pill for PKU shows promise in small teen trial